White House

Politics By Lev Facher

As Omicron recedes, White House shifts to a more targeted Covid strategy

Politics By Lev Facher

In State of the Union, Biden walks a fine line on Covid optimism

D.C. Diagnosis By Nicholas Florko

The FDA’s promised menthol ban is about to face a critical test

Politics By Nicholas Florko

Pfizer made Trump’s vaccine push harder than it needed to be, former Warp Speed official alleges in new book

D.C. Diagnosis By Nicholas Florko

Is the Senate gearing up to actually pass drug pricing legislation?

First Opinion By Arush Lal

Three urgent priorities for the National Security Council to strengthen global health security and biodefense

Exclusive By Lev Facher

Inside the culture of fear in Eric Lander’s White House science office

Politics By Darlene Superville — Associated Press

Biden to tap Francis Collins, OSTP deputy to split the role of his ousted science adviser

Politics By Nicholas Florko

Senate narrowly confirms Robert Califf to lead the FDA

Politics By Nicholas Florko and Rachel Cohrs

With no votes to spare, Senate advances Califf’s FDA nomination toward final vote

Politics By Lev Facher

Following Lander’s resignation, here’s who might be in line for White House science adviser

Politics By Rachel Cohrs and Nicholas Florko

Senate pushes toward a vote on Robert Califf, Biden’s pick for FDA

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Eric Lander’s resignation, FDA’s about-face, & Pfizer’s lucrative pandemic

Matt's Take By Matthew Herper

The fall of Eric Lander and the end of science’s ‘big ego’ era

D.C. Diagnosis By Nicholas Florko

A no good, very bad week for Biden’s science agenda

Politics By Lev Facher

Eric Lander resigns — potentially imperiling the rest of Biden’s scientific agenda

Politics By Nicholas Florko and Rachel Cohrs

In a bid to save Biden’s FDA pick, doctors and public health groups are mounting a rare pressure campaign

Politics By Lev Facher

Lander’s all-staff mea culpa is the latest in a string of apologies

Politics By Nicholas Florko

Biden’s FDA pick Califf vows to reform accelerated approvals to win a key senator’s support

Politics By Lev Facher

Lander: New cancer plan ‘more ambitious by far’ than original moonshot

Health Tech By Casey Ross

As the telemedicine industry rapidly expands, the Biden administration takes a closer look at who’s benefiting

Exclusive By Lev Facher

Key lawmaker: ARPA-H won’t be part of NIH

Politics By Lev Facher

Biden once pledged to ‘cure cancer.’ His new approach is far more modest

Health By Nicholas Florko

Despite Biden’s big promises and a far better understanding of the virus, Covid-19 is still raging through the nation’s prisons

Exclusive By Nicholas Florko and Rachel Cohrs

More Democrats flag ‘questions,’ remain uncertain about Biden’s FDA pick, Robert Califf

D.C. Diagnosis By Nicholas Florko

Democrats aren’t ready to support Biden’s FDA pick, Robert Califf

Exclusive By Rachel Cohrs

The Biden administration used billions in hospital Covid-19 funds to pay drugmakers

Health By Rachel Cohrs

Can mailing free Covid-19 tests turn Biden’s pandemic response around?

Health By Andrew Joseph, Helen Branswell, Nicholas Florko and Lev Facher

13 big questions about Biden’s response to Omicron, as Congress prepares to grill Fauci, Walensky, and other top officials